WHO ICTRP trial
Prevention and treatment of neratinib maleate tablets-associated diarrhea with…
ITMCTR2025000951 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting
Key facts
| Trial ID | ITMCTR2025000951 |
|---|---|
| Public title | Prevention and treatment of neratinib maleate tablets-associated diarrhea with traditional Chinese medicine prescriptions: a prospective single-center open-label clinical study |
| Scientific title | Prevention and treatment of neratinib maleate tablets-associated diarrhea with traditional Chinese medicine prescriptions: a prospective single-center open-label clinical study |
| Primary sponsor | China Medical University Shengjing Hospital |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Not Recruiting |
| Study type | Treatment study |
| Phase | Pilot clinical trial |
| Countries | China |
| Conditions | Diarrhea |
| Interventions | intervention group:In the combination of traditional Chinese medicine prescriptions and Neratinib tablets, when diarrhea is uncontrollable, loperamide treatment is needed. |
| Registration date | May 12, 2025 |
| Target size | intervention group:30 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: